To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CASP4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
396 supporting clones for gene CASP4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK057094 small intestine .a 1 to 2150 2 to 2151 R134C tiling clone, available from FLJ,   2151/2151
(100 %)
3 diff
(99.9 %id)
DA915987 small intestine .a 1 to 507 2 to 511   capped   510/510
(100 %)
3 diff
(99.5 %id)
CN261701 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 809 to 1608 1 to 799       799/799
(100 %)
3 diff
(99.7 %id)
BF666770 brain, primitive neuroectoderm .a 837 to 1398 1 to 562       562/562
(100 %)
1 diff
(99.9 %id)
NM_001225.3   .a 838 to 2156 1 to 1319 exact RefSeq,   1319/1319
(100 %)
0 diff
(100 %id)
BX503828   .a 839 to 1114 1 to 276       276/276
(100 %)
1 diff
(99.7 %id)
CB106882 Liver .a 840 to 1269 1 to 429       429/429
(100 %)
2 diff
(99.6 %id)
CB128832 Liver .a 840 to 1542 1 to 703       703/708
(99 %)
2 diff
(99.8 %id)
CB116906 Liver .a 840 to 1396 1 to 557       557/557
(100 %)
1 diff
(99.9 %id)
BX473332   .a 841 to 1427 1 to 588       588/590
(99 %)
6 diff
(99.0 %id)
DB261226 uterus .a 841 to 1396 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
CB106499 Liver .a 842 to 1300 1 to 459       459/459
(100 %)
1 diff
(99.8 %id)
DA585455 lung .a 843 to 1396 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DB152858 thymus .a 843 to 1419 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
TI_154131813   .a 846 to 1691 73 to 914     Submitted on the opposite strand 842/1082
(77 %)
19 diff
(98.3 %id)
DA380410 thalamus .a 847 to 1382 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
DA439463 tongue, tumor tissue .a 850 to 1382 2 to 535   capped   531/534
(99 %)
4 diff
(99.3 %id)
DT215961 brain .a 850 to 1548 1 to 699       699/699
(100 %)
4 diff
(99.5 %id)
DA846054 placenta .a 850 to 1418 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DA947280 Spleen .a 850 to 1404 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
CB133439 Liver .a 851 to 1360 5 to 514       510/514
(99 %)
6 diff
(98.9 %id)
BG572056 placenta .a 853 to 1539 1 to 686       686/687
(99 %)
12 diff
(98.3 %id)
DC417062 trachea .a 855 to 1408 1 to 554       554/554
(100 %)
3 diff
(99.5 %id)
AI249361 adenocarcinoma, Pancreas .a 858 to 1266 1 to 409     Submitted on the opposite strand 409/410
(99 %)
5 diff
(98.8 %id)
BG468518 adenocarcinoma cell line, colon .a 859 to 1497 1 to 639       639/639
(100 %)
2 diff
(99.7 %id)
CD102536 Pooled-Skin .a 859 to 1498 1 to 645       645/771
(83 %)
15 diff
(98.1 %id)
BG398850 Kidney .a 860 to 1620 1 to 759       759/942
(80 %)
27 diff
(97.2 %id)
BG504723 embryonal carcinoma, testis .a 860 to 1534 1 to 682       682/682
(100 %)
16 diff
(97.7 %id)
BG530670 embryonal carcinoma, testis .a 860 to 1382 1 to 534       534/1024
(52 %)
18 diff
(98.3 %id)
BX495662 Liver .a 861 to 1376 10 to 526       517/526
(98 %)
8 diff
(98.5 %id)
CB133417 Liver .a 861 to 1021 12 to 174       163/163
(100 %)
3 diff
(98.2 %id)
CA418260 Bone, Human Chondrosarcoma Cell Line .a 861 to 1616 17 to 770     Submitted on the opposite strand 754/754
(100 %)
2 diff
(99.8 %id)
CB993683 placenta, pre-eclamptic placenta .a 862 to 1457 23 to 621       599/805
(74 %)
15 diff
(98.2 %id)
DB130843 thymus .a 862 to 1402 2 to 544   capped   543/543
(100 %)
3 diff
(99.5 %id)
U25804 thymus .a 863 to 2125 1 to 1263 exact     1263/1263
(100 %)
1 diff
(100.0 %id)
CR613155 placenta .a 864 to 2150 1 to 1287 exact     1287/1287
(100 %)
0 diff
(100 %id)
BX439343 placenta .a 864 to 1635 1 to 773   fully sequenced,   773/773
(100 %)
1 diff
(99.9 %id)
BU942622 mixed (pool of 40 RNAs) .a 865 to 1632 1 to 769       769/773
(99 %)
8 diff
(99.0 %id)
FN054473 breast carcinoma .a 866 to 959 1 to 94       94/94
(100 %)
2 diff
(97.9 %id)
BF213782 bone marrow, from acute myelogenous leukemia .a 866 to 1459 1 to 602       602/841
(71 %)
33 diff
(96.1 %id)
BG540426 lung .a 866 to 1660 1 to 797       797/798
(99 %)
11 diff
(98.7 %id)
DW454551 Liver .a 867 to 1027 17 to 177       161/180
(89 %)
17 diff
(90.6 %id)
TI_57234825   .a 867 to 1675 34 to 842       809/842
(96 %)
9 diff
(99.0 %id)
DA045019 bladder .a 868 to 1423 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
CD639289 pooled .a 868 to 1533 1 to 666       666/667
(99 %)
5 diff
(99.3 %id)
DB105468 thymus .a 868 to 1426 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
CD683705 normal nasopharynx .a 869 to 1542 37 to 712       676/712
(94 %)
9 diff
(98.8 %id)
CD691795 normal nasopharynx .a 869 to 1423 21 to 574       554/574
(96 %)
6 diff
(99.0 %id)
CD701965 normal nasopharynx .a 869 to 1335 37 to 502       466/502
(92 %)
7 diff
(98.7 %id)
CD702684 normal nasopharynx .a 869 to 1481 18 to 629       612/629
(97 %)
10 diff
(98.5 %id)
BU181179 large cell carcinoma, lung .a 869 to 1735 1 to 865       865/866
(99 %)
11 diff
(98.8 %id)
CA453743 mixed (pool of 40 RNAs) .a 869 to 1507 1 to 646       646/853
(75 %)
11 diff
(98.8 %id)
DB132766 thymus .a 869 to 1413 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
AK225751 Spleen .a 870 to 2154 1 to 1288 K44R Y45N Y46I D47T A48M ... AAA   1286/1288
(99 %)
2 diff
(99.9 %id)
BI909591 leukocyte .a 870 to 1675 1 to 806       806/806
(100 %)
3 diff
(99.7 %id)
BU933573 mixed (pool of 40 RNAs) .a 870 to 1641 1 to 774       774/774
(100 %)
16 diff
(98.0 %id)
CD102950 Pooled-Skin .a 870 to 1563 1 to 704       704/745
(94 %)
21 diff
(97.2 %id)
CD522428 pooled .a 870 to 1457 1 to 588       588/735
(80 %)
3 diff
(99.6 %id)
DB133866 thymus .a 870 to 1413 2 to 547   capped   546/549
(99 %)
6 diff
(99.0 %id)
Z48810 placenta .a 870 to 2150 1 to 1281 exact AAA   1281/1281
(100 %)
1 diff
(100.0 %id)
BE439651 Trabecular meshwork .a 871 to 1554 1 to 685       685/685
(100 %)
4 diff
(99.5 %id)
BF698342 brain, primitive neuroectoderm .a 871 to 1596 1 to 723       723/910
(79 %)
26 diff
(97.2 %id)
BF698442 brain, primitive neuroectoderm .a 871 to 1601 1 to 732       732/836
(87 %)
28 diff
(96.7 %id)
BG117256 adenocarcinoma, cell line, Liver .a 871 to 1594 1 to 722       722/952
(75 %)
7 diff
(99.3 %id)
BG540874 lung .a 871 to 1626 1 to 756       756/899
(84 %)
37 diff
(95.9 %id)
BG531120 embryonal carcinoma, testis .a 871 to 1539 1 to 669       669/669
(100 %)
3 diff
(99.6 %id)
BG572762 placenta .a 871 to 1462 1 to 592       592/592
(100 %)
1 diff
(99.9 %id)
CB119920 Liver .a 871 to 1378 1 to 509       509/509
(100 %)
1 diff
(99.9 %id)
CB141549 Liver .a 871 to 1544 1 to 674       674/674
(100 %)
1 diff
(99.9 %id)
BC017839 Testis, embryonal carcinoma .a 872 to 2148 1 to 1277 exact available from MGC, AAA   1277/1277
(100 %)
4 diff
(99.7 %id)
BG332702 large cell carcinoma, lung .a 872 to 1585 1 to 711       711/714
(99 %)
13 diff
(98.2 %id)
DB153941 thymus .a 872 to 1439 2 to 570   capped   569/569
(100 %)
3 diff
(99.5 %id)
DA989391 synovial membrane tissue from rheumatioidarthritis .a 873 to 1426 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
CR622245 Placenta Cot 25-normalized .a 874 to 2122 1 to 1249 exact     1249/1249
(100 %)
0 diff
(100 %id)
U28014   .a 874 to 2154 1 to 1281 exact     1281/1282
(99 %)
2 diff
(99.9 %id)
AA297322 Embryo, 8 weeks .a 875 to 1099 1 to 225       225/225
(100 %)
0 diff
(100 %id)
BI333442 cervical carcinoma cell line, cervix .a 875 to 1655 1 to 781       781/781
(100 %)
7 diff
(99.2 %id)
CD695271 normal nasopharynx .a 876 to 1337 39 to 500       462/500
(92 %)
7 diff
(98.6 %id)
U28976   .a 878 to 2155 1 to 1278 exact     1278/1278
(100 %)
1 diff
(100.0 %id)
AA297250   .a 879 to 1121 1 to 243       243/286
(84 %)
3 diff
(99.0 %id)
DN997303 breast cancer, Mammary gland (cancer tissue) .a 879 to 1644 8 to 773       766/773
(99 %)
9 diff
(98.9 %id)
AA171968   .a 881 to 1290 1 to 411       411/412
(99 %)
6 diff
(98.6 %id)
BI821667 pooled brain, lung, testis .a 881 to 1670 1 to 796       796/1037
(76 %)
12 diff
(98.9 %id)
TI_57199187   .a 881 to 1670 69 to 864       796/1105
(72 %)
18 diff
(98.4 %id)
BG120597 adenocarcinoma, cell line, Liver .a 882 to 1626 1 to 742       740/959
(77 %)
14 diff
(98.6 %id)
BG400771 Kidney .a 883 to 1608 1 to 724       724/725
(99 %)
7 diff
(99.1 %id)
BF207727 bladder, carcinoma, cell line .a 884 to 1550 1 to 664       666/699
(95 %)
10 diff
(98.6 %id)
BG436745 large cell carcinoma, lung .a 884 to 1790 1 to 907       907/907
(100 %)
27 diff
(97.1 %id)
BX280404 large cell carcinoma, lung .a 885 to 1387 1 to 503       503/503
(100 %)
0 diff
(100 %id)
BC008060 Colon, adenocarcinoma .a 885 to 2155 1 to 1273 P10A L11T K12* available from MGC, AAA   1273/1273
(100 %)
4 diff
(99.7 %id)
BM556145 amelanotic melanoma, cell line, skin .a 887 to 1835 1 to 950       950/1099
(86 %)
19 diff
(98.3 %id)
BM808943 amelanotic melanoma, cell line, skin .a 888 to 1835 27 to 983       955/1079
(88 %)
26 diff
(97.6 %id)
BQ710338 Spleen .a 888 to 1657 1 to 779       779/872
(89 %)
11 diff
(98.8 %id)
CR601555 Placenta Cot 25-normalized .a 890 to 2126 1 to 1237 exact     1237/1237
(100 %)
0 diff
(100 %id)
AL549021 placenta, Placenta Cot 25-normalized .a 890 to 1487 1 to 598   fully sequenced,   598/598
(100 %)
0 diff
(100 %id)
BG259274 embryonal carcinoma, cell line, testis .a 890 to 1640 1 to 758       758/1234
(61 %)
12 diff
(99.1 %id)
R07558 liver and spleen .a 891 to 1251 1 to 372       372/435
(85 %)
16 diff
(96.4 %id)
BQ217132 large cell carcinoma, lung .a 891 to 1609 1 to 721       721/927
(77 %)
14 diff
(98.5 %id)
BU180417 ductal carcinoma, cell line, Pancreas .a 891 to 1748 1 to 865       865/922
(93 %)
23 diff
(97.6 %id)
BQ687713 ductal carcinoma, cell line, Pancreas .a 891 to 1775 1 to 890       890/955
(93 %)
15 diff
(98.5 %id)
DN995145 brain, whole brain .a 891 to 1490 8 to 605       598/605
(98 %)
10 diff
(98.4 %id)
BM456310 lymph, lymphoma, cell line .a 892 to 1691 1 to 802       802/815
(98 %)
3 diff
(99.7 %id)
AW957798   .a 894 to 1080 1 to 187       187/320
(58 %)
7 diff
(97.9 %id)
AW966855   .a 894 to 1502 1 to 610       610/610
(100 %)
15 diff
(97.6 %id)
CR595643 Placenta Cot 25-normalized .a 894 to 2154 1 to 1261 exact tiling clone,   1261/1261
(100 %)
0 diff
(100 %id)
BX345834 Placenta Cot 25-normalized .a 894 to 1589 1 to 696   fully sequenced,   696/696
(100 %)
0 diff
(100 %id)
BQ051905 blood, natural killer cells, cell line .a 895 to 1835 1 to 953       951/1057
(89 %)
40 diff
(96.3 %id)
R97462 liver and spleen .a 897 to 1294 1 to 400       400/465
(86 %)
9 diff
(98.1 %id)
BE616597 adenocarcinoma, Pancreas .a 897 to 1620 38 to 758       721/758
(95 %)
9 diff
(98.9 %id)
BM822702 stomach .a 897 to 1381 1 to 485       485/485
(100 %)
0 diff
(100 %id)
BG035170 adenocarcinoma, cell line, Liver .a 899 to 1683 1 to 793       793/1105
(71 %)
21 diff
(98.1 %id)
BG678955 skin, squamous cell carcinoma .a 900 to 1624 1 to 725       725/725
(100 %)
0 diff
(100 %id)
BU152578 carcinoma, cell line, Prostate .a 911 to 1692 1 to 790       790/890
(88 %)
17 diff
(98.1 %id)
BU788176 insulinoma, Pancreas .a 912 to 1409 1 to 501       505/501
(100 %)
11 diff
(97.9 %id)
BG258466 embryonal carcinoma, cell line, testis .a 913 to 1682 1 to 779       779/969
(80 %)
22 diff
(97.8 %id)
BE616611 adenocarcinoma, Pancreas .a 914 to 1684 17 to 781       769/922
(83 %)
21 diff
(97.8 %id)
CR596626 Placenta Cot 25-normalized .a 915 to 2110 1 to 1196       1196/1196
(100 %)
0 diff
(100 %id)
CR749010 embryonal carcinoma, cell line, testis .a 915 to 1402 14 to 501       492/501
(98 %)
6 diff
(98.9 %id)
AL550539 placenta, Placenta Cot 25-normalized .a 915 to 1487 1 to 573   fully sequenced,   573/573
(100 %)
0 diff
(100 %id)
BX359602 Placenta Cot 25-normalized .a 915 to 1943 1 to 1023       1025/1023
(100 %)
11 diff
(99.0 %id)
R98763 liver and spleen .a 915 to 1226 9 to 321       314/321
(97 %)
7 diff
(97.9 %id)
BE292850 adenocarcinoma cell line, colon .a 915 to 1584 12 to 680   available from MGC,   673/720
(93 %)
11 diff
(98.5 %id)
BE616654 adenocarcinoma, Pancreas .a 915 to 1705 16 to 807       796/883
(90 %)
35 diff
(96.1 %id)
BM799344 Ascites, stomach .a 915 to 1428 16 to 530       519/530
(97 %)
6 diff
(98.9 %id)
ES308612 beard hair, skin .a 916 to 1056 1 to 138       138/138
(100 %)
0 diff
(100 %id)
AW239376 lung, cell line .a 916 to 1550 1 to 635       635/637
(99 %)
7 diff
(99.0 %id)
BE616812 adenocarcinoma, Pancreas .a 916 to 1664 57 to 811       758/951
(79 %)
17 diff
(98.3 %id)
CB132522 Liver .a 917 to 1378 1 to 462       462/462
(100 %)
0 diff
(100 %id)
N33737 melanocyte .a 931 to 1116 1 to 186       186/193
(96 %)
1 diff
(99.5 %id)
DR005182 Prostate .a 960 to 1661 1 to 699       699/702
(99 %)
7 diff
(99.1 %id)
BF173153 blood .a 965 to 1227 1 to 264       264/264
(100 %)
2 diff
(99.3 %id)
AW578271 colon_normal .a 1001 to 1626 42 to 668       627/668
(93 %)
8 diff
(98.9 %id)
BE000451 breast_normal .a 1012 to 1424 413 to 1     Submitted on the opposite strand 413/413
(100 %)
1 diff
(99.8 %id)
CB136090 Liver .a 1030 to 1684 1 to 655       655/655
(100 %)
0 diff
(100 %id)
CB134604 Liver .a 1030 to 1648 1 to 619       619/619
(100 %)
0 diff
(100 %id)
CB159078 Liver .a 1030 to 1648 1 to 619       619/619
(100 %)
0 diff
(100 %id)
CB135471 Liver .a 1031 to 1389 1 to 359       359/359
(100 %)
0 diff
(100 %id)
CB144587 Liver .a 1038 to 1172 1 to 135       135/135
(100 %)
0 diff
(100 %id)
BX381102 Placenta Cot 25-normalized .a 1046 to 1834 142 to 957       765/957
(79 %)
51 diff
(94.7 %id)
BG109883 Bone, osteosarcoma, cell line .a 1052 to 1750 1 to 695       695/920
(75 %)
10 diff
(99.0 %id)
BF247596 hypernephroma, Kidney .a 1054 to 1498 275 to 722       448/768
(58 %)
24 diff
(96.9 %id)
BQ672285 epidermoid carcinoma, cell line, salivary gland .a 1083 to 1939 1 to 866       866/914
(94 %)
14 diff
(98.5 %id)
CF127052 Chondrosarcoma Lung Metastasis cell lines, lung .a 1084 to 1898 1 to 813       815/813
(100 %)
8 diff
(99.1 %id)
TI_154190154   .a 1084 to 2045 51 to 1001       953/1023
(93 %)
29 diff
(97.2 %id)
AL702469 human skeletal muscle .a 1090 to 1273 1 to 183       183/183
(100 %)
1 diff
(99.5 %id)
AW383096 head_neck .a 1091 to 1746 1 to 650       650/654
(99 %)
24 diff
(96.4 %id)
FN125058 breast carcinoma .a 1094 to 1187 1 to 96       96/97
(98 %)
4 diff
(95.9 %id)
AA296695 aorta .a 1110 to 1457 1 to 349       349/394
(88 %)
2 diff
(99.5 %id)
TI_159702084   .a 1116 to 1877 68 to 827     Submitted on the opposite strand 760/1135
(66 %)
9 diff
(99.3 %id)
R81031 placenta .a 1118 to 1442 1 to 330       330/426
(77 %)
10 diff
(97.7 %id)
BU934157 mixed (pool of 40 RNAs) .a 1119 to 1690 1 to 574       574/874
(65 %)
9 diff
(99.0 %id)
CB129974 Liver .a 1134 to 1760 1 to 627       627/627
(100 %)
1 diff
(99.9 %id)
BM989506 lung, Metastatic Chondrosarcoma .a 1142 to 1893 14 to 759     Submitted on the opposite strand 748/746
(100 %)
10 diff
(98.7 %id)
W69820 heart .a 1149 to 1593 1 to 446       446/446
(100 %)
1 diff
(99.8 %id)
W92853 heart .a 1149 to 1550 1 to 404       404/406
(99 %)
3 diff
(99.3 %id)
FN164626 breast carcinoma .a 1167 to 1253 1 to 87       87/87
(100 %)
0 diff
(100 %id)
BE006332 breast_normal .a 1195 to 1625 267 to 697       431/700
(61 %)
10 diff
(98.6 %id)
AL576631 placenta, Placenta Cot 25-normalized .a 1196 to 2122 927 to 1       927/927
(100 %)
20 diff
(97.9 %id)
BG938769 Bone, Hip .a 1204 to 1801 1 to 598       598/598
(100 %)
4 diff
(99.4 %id)
AW797593 uterus .a 1215 to 1436 13 to 241       236/241
(97 %)
7 diff
(97.1 %id)
BM907500 large cell carcinoma, lung .a 1218 to 2154 966 to 16   AAA Submitted on the opposite strand 951/953
(99 %)
26 diff
(97.3 %id)
TI_154110420   .a 1234 to 2155 994 to 86   AAA   909/982
(92 %)
17 diff
(98.3 %id)
CB159260 Liver .a 1255 to 1835 586 to 6     Submitted on the opposite strand 581/586
(99 %)
0 diff
(100 %id)
BE814577 breast_normal .a 1265 to 1431 170 to 4       167/170
(98 %)
0 diff
(100 %id)
W68093 heart .a 1280 to 1733 1 to 449   fully sequenced,   449/449
(100 %)
0 diff
(100 %id)
TI_149309575   .a 1281 to 2154 959 to 88   AAA   872/1004
(86 %)
6 diff
(99.5 %id)
C00530   .a 1282 to 1574 1 to 296       296/296
(100 %)
9 diff
(97.0 %id)
BU163523 ductal carcinoma, cell line, Pancreas .a 1291 to 2157 874 to 4     Submitted on the opposite strand 871/889
(97 %)
11 diff
(98.8 %id)
BM696793 eye, lens .a 1302 to 1722 1 to 421   fully sequenced,   421/421
(100 %)
0 diff
(100 %id)
BQ300671 bladder_tumor .a 1317 to 1677 379 to 20       360/389
(92 %)
0 diff
(100 %id)
AA029875 uterus .a 1334 to 1884 1 to 558   fully sequenced,   558/558
(100 %)
10 diff
(98.3 %id)
CR609637 thymus .a 1349 to 2153 1 to 805       805/805
(100 %)
0 diff
(100 %id)
TI_154115331   .a 1356 to 2155 871 to 85   AAA   787/956
(82 %)
13 diff
(98.7 %id)
BX415045 thymus .a 1363 to 2153 15 to 805   fully sequenced,   791/805
(98 %)
7 diff
(99.2 %id)
W58133 heart .a 1377 to 1781 1 to 420   fully sequenced,   419/419
(100 %)
20 diff
(95.3 %id)
AW383106 head_neck .a 1378 to 2024 643 to 1       643/652
(98 %)
9 diff
(98.7 %id)
BG109718 Bone, osteosarcoma, cell line .a 1385 to 2155 1 to 766   AAA   766/766
(100 %)
6 diff
(99.3 %id)
BG623828 placenta .a 1388 to 2156 1 to 781       781/832
(93 %)
30 diff
(96.4 %id)
BF847469 lung_normal .a 1389 to 1761 9 to 381       373/381
(97 %)
9 diff
(97.7 %id)
BG027360 Bone, osteosarcoma, cell line .a 1391 to 1956 1 to 567       567/934
(60 %)
17 diff
(98.2 %id)
CA306761 Alveolar Macrophage, lung .a 1396 to 2150 770 to 17   AAA   754/754
(100 %)
2 diff
(99.8 %id)
CA448151 Chondrosarcoma, Left Pubic Bone .a 1417 to 2155 756 to 19   AAA   738/738
(100 %)
2 diff
(99.8 %id)
CD367814 Alveolar Macrophage, lung .a 1417 to 2150 749 to 17   AAA   733/733
(100 %)
2 diff
(99.8 %id)
BU687960 lung .a 1419 to 2154 750 to 15   AAA   736/736
(100 %)
1 diff
(99.9 %id)
BE925180 amnion_normal .a 1425 to 1831 13 to 433       417/433
(96 %)
29 diff
(93.4 %id)
AL573372 placenta, Placenta Cot 25-normalized .a 1426 to 2121 703 to 6   fully sequenced,   698/703
(99 %)
6 diff
(99.2 %id)
AL574479 placenta, Placenta Cot 25-normalized .a 1426 to 2100 687 to 12   fully sequenced,   676/687
(98 %)
5 diff
(99.3 %id)
CB135526 Liver .a 1432 to 1875 444 to 1     Submitted on the opposite strand 444/444
(100 %)
1 diff
(99.8 %id)
N79646 multiple sclerosis lesions .a 1433 to 1866 1 to 443   fully sequenced,   443/443
(100 %)
12 diff
(97.3 %id)
TI_154191223   .a 1435 to 2153 49 to 767   AAA   719/719
(100 %)
3 diff
(99.6 %id)
CF129507 Chondrosarcoma Lung Metastasis cell lines, lung .a 1438 to 2151 1 to 714       714/714
(100 %)
1 diff
(99.9 %id)
R24084 placenta .a 1439 to 1689 1 to 254       254/282
(90 %)
4 diff
(98.6 %id)
TI_149278446   .a 1445 to 2150 785 to 81   AAA   705/705
(100 %)
3 diff
(99.6 %id)
TI_149296735   .a 1454 to 2155 794 to 97   AAA   698/764
(91 %)
7 diff
(99.1 %id)
CA449081 Chondrosarcoma, Left Pubic Bone .a 1455 to 2155 718 to 19   AAA   700/700
(100 %)
2 diff
(99.8 %id)
AI446126 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1457 to 2155 697 to 1       697/714
(97 %)
34 diff
(95.3 %id)
BU625086 cell lines, Enchondroma .a 1457 to 2154 715 to 19   AAA   697/739
(94 %)
2 diff
(99.8 %id)
BG938768 Bone, Hip .a 1459 to 2129 679 to 9       671/679
(98 %)
2 diff
(99.8 %id)
CA309705 Alveolar Macrophage, lung .a 1460 to 2150 706 to 17   AAA   690/690
(100 %)
2 diff
(99.8 %id)
BQ016279 lung, Metastatic Chondrosarcoma .a 1465 to 2150 701 to 17   AAA   685/685
(100 %)
3 diff
(99.6 %id)
BM969320 lung, Primary Lung Epithelial Cells .a 1466 to 2150 700 to 17   AAA   684/684
(100 %)
3 diff
(99.6 %id)
AI963274 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1467 to 2155 686 to 1       686/686
(100 %)
5 diff
(99.3 %id)
AW798291 uterus .a 1469 to 1630 12 to 173       162/176
(92 %)
3 diff
(98.3 %id)
CF128625 Chondrosarcoma Lung Metastasis cell lines, lung .a 1471 to 1857 1 to 387       387/387
(100 %)
10 diff
(97.5 %id)
BQ011268 placenta .a 1472 to 2150 694 to 17   AAA   678/678
(100 %)
3 diff
(99.6 %id)
AW580447 head_neck .a 1473 to 1881 33 to 440       408/442
(92 %)
11 diff
(97.6 %id)
T63181 lung .a 1477 to 1552 1 to 76       76/76
(100 %)
0 diff
(100 %id)
BU615423 Bone, Human Chondrosarcoma Cell Line .a 1477 to 2154 689 to 13   AAA   677/679
(99 %)
3 diff
(99.6 %id)
BQ016737 lung, Lung Focal Fibrosis .a 1479 to 2150 690 to 19   AAA   672/672
(100 %)
2 diff
(99.8 %id)
BM969255 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1487 to 2155 687 to 19   AAA   669/669
(100 %)
1 diff
(99.9 %id)
BQ774727 Bone, Human Chondrosarcoma Cell Line .a 1487 to 2154 682 to 15   AAA   668/668
(100 %)
1 diff
(99.9 %id)
CA309869 Alveolar Macrophage, lung .a 1487 to 2155 687 to 19   AAA   669/669
(100 %)
1 diff
(99.9 %id)
AI745453 ovary, tumor, 5 pooled (see description) .a 1493 to 2154 655 to 2       654/708
(92 %)
17 diff
(97.6 %id)
CF130302 Chondrosarcoma Lung Metastasis cell lines, lung .a 1506 to 2152 1 to 648   AAA   648/648
(100 %)
2 diff
(99.7 %id)
TI_154192255   .a 1506 to 2152 51 to 698   AAA   648/648
(100 %)
2 diff
(99.7 %id)
AA262530 germinal center B cell .a 1514 to 1866 1 to 353   fully sequenced,   353/353
(100 %)
1 diff
(99.8 %id)
AW383128 head_neck .a 1519 to 2046 540 to 13       528/540
(97 %)
6 diff
(98.9 %id)
W17320 lung .a 1522 to 2021 15 to 513       499/518
(96 %)
9 diff
(98.3 %id)
BQ026835 Chondrosarcoma, Left Pubic Bone .a 1526 to 2150 640 to 17   AAA   624/624
(100 %)
4 diff
(99.4 %id)
CA439432 lung, Metastatic Chondrosarcoma .a 1526 to 2150 638 to 14   AAA   625/625
(100 %)
5 diff
(99.2 %id)
W68027 heart .a 1543 to 1678 1 to 136       136/145
(93 %)
1 diff
(99.4 %id)
AI624280 adenocarcinoma, Pancreas .a 1547 to 2150 617 to 14   AAA   604/604
(100 %)
10 diff
(98.4 %id)
W58386.
matches multiple genes
heart .a 1555 to 2154 602 to 3     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base), also hits gene C13orf15 600/602
(99 %)
2 diff
(99.7 %id)
BX392793 Placenta Cot 25-normalized .a 1559 to 2154 594 to 1   fully sequenced,   594/594
(100 %)
4 diff
(99.4 %id)
AA491101 germinal center B cell .a 1561 to 1876 1 to 316   fully sequenced,   316/316
(100 %)
1 diff
(99.7 %id)
BU626647 Alveolar Macrophage, lung .a 1563 to 2150 601 to 17   AAA   585/585
(100 %)
5 diff
(99.2 %id)
BU624575 cell lines, Enchondroma .a 1568 to 2150 599 to 17   AAA   583/583
(100 %)
4 diff
(99.4 %id)
AW806576 stomach .a 1581 to 2049 497 to 31       467/497
(93 %)
2 diff
(99.6 %id)
AI421830 brain, glioblastoma (pooled) .a 1583 to 2150 568 to 1       568/568
(100 %)
1 diff
(99.9 %id)
AW008115 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1583 to 2151 569 to 1       569/569
(100 %)
6 diff
(99.0 %id)
CF130267 Chondrosarcoma Lung Metastasis cell lines, lung .a 1599 to 2155 1 to 557   AAA   557/557
(100 %)
1 diff
(99.9 %id)
TI_154192216   .a 1599 to 2155 51 to 607   AAA   557/557
(100 %)
1 diff
(99.9 %id)
AI762827 B-cell, chronic lymphotic leukemia .a 1601 to 2152 555 to 4       552/555
(99 %)
24 diff
(95.7 %id)
BQ672682 epidermoid carcinoma, cell line, salivary gland .a 1604 to 2150 1 to 547   AAA   547/547
(100 %)
1 diff
(99.9 %id)
BX412254 placenta .a 1605 to 2150 548 to 1   fully sequenced,   548/548
(100 %)
3 diff
(99.5 %id)
TI_153992116   .a 1605 to 2154 641 to 91   AAA   551/551
(100 %)
32 diff
(94.2 %id)
BQ575218 Chondrosarcoma Grade II, Left Pelvis .a 1609 to 2155 566 to 19   AAA   548/548
(100 %)
7 diff
(98.8 %id)
W93303 heart .a 1613 to 2150 542 to 1       542/547
(99 %)
17 diff
(96.9 %id)
AA296998 adipose tissue, white .a 1616 to 1905 1 to 290       290/290
(100 %)
1 diff
(99.7 %id)
AI249249 adenocarcinoma, Pancreas .a 1616 to 2151 536 to 1       536/536
(100 %)
10 diff
(98.2 %id)
AI687969 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1616 to 2150 546 to 12   AAA   535/535
(100 %)
12 diff
(97.8 %id)
AW950239   .a 1617 to 2155 1 to 539   AAA   539/539
(100 %)
1 diff
(99.9 %id)
BG236240 blood, lymphocyte .a 1619 to 2153 535 to 1       535/535
(100 %)
1 diff
(99.9 %id)
DB331654 small intestine .a 1620 to 2150 532 to 1       532/532
(100 %)
2 diff
(99.7 %id)
AI128358 placenta .a 1622 to 2156 535 to 1       535/535
(100 %)
4 diff
(99.3 %id)
AA093816   .a 1624 to 1763 1 to 139       139/140
(99 %)
5 diff
(96.5 %id)
CD640508 pooled .a 1631 to 2155 1 to 525   AAA   525/525
(100 %)
3 diff
(99.5 %id)
T62557 lung .a 1634 to 2142 532 to 13       518/539
(96 %)
13 diff
(97.6 %id)
AI189675 placenta .a 1636 to 2154 520 to 2       519/569
(91 %)
6 diff
(99.0 %id)
FN097197 breast carcinoma .a 1649 to 1735 91 to 2     Submitted on the opposite strand 90/97
(92 %)
3 diff
(97.0 %id)
CB121965 Liver .a 1650 to 2150 518 to 18   AAA Submitted on the opposite strand 501/501
(100 %)
1 diff
(99.9 %id)
CB118394 Liver .a 1650 to 2155 523 to 18   AAA Submitted on the opposite strand 506/506
(100 %)
1 diff
(99.9 %id)
FN091674 breast carcinoma .a 1651 to 1737 88 to 1     Submitted on the opposite strand 88/97
(90 %)
4 diff
(95.9 %id)
AI762548 B-cell, chronic lymphotic leukemia .a 1656 to 2150 507 to 13   AAA   495/496
(99 %)
2 diff
(99.6 %id)
EL593693 epidermis, skin .a 1657 to 1994 1 to 338       338/362
(93 %)
5 diff
(98.7 %id)
EL593696 epidermis, skin .a 1657 to 1994 1 to 338       338/362
(93 %)
7 diff
(98.1 %id)
EL593697 epidermis, skin .a 1657 to 1993 1 to 337       337/363
(92 %)
5 diff
(98.7 %id)
EL593704 epidermis, skin .a 1658 to 1994 360 to 24     Submitted on the opposite strand 337/361
(93 %)
3 diff
(99.2 %id)
BU735303 eye, lens .a 1661 to 2152 510 to 19   fully sequenced, AAA   492/492
(100 %)
4 diff
(99.2 %id)
AI371047 lung .a 1670 to 2153 487 to 4       484/487
(99 %)
2 diff
(99.6 %id)
AA991681   .a 1676 to 2157 484 to 3   tiling clone,   482/484
(99 %)
1 diff
(99.8 %id)
AW780285 colon, moderately-differentiated adenocarcinoma .a 1682 to 2149 468 to 1       468/468
(100 %)
1 diff
(99.8 %id)
AI038251 liver and spleen .a 1691 to 2156 466 to 1       466/470
(99 %)
3 diff
(99.4 %id)
AI189740 placenta .a 1691 to 2151 459 to 1       459/529
(86 %)
9 diff
(98.3 %id)
AW800101 uterus .a 1695 to 1897 10 to 212       203/241
(84 %)
8 diff
(96.7 %id)
BM694325 eye, RPE and Choroid .a 1696 to 2150 1 to 455   fully sequenced, AAA   455/455
(100 %)
1 diff
(99.8 %id)
AI128269 placenta .a 1697 to 2155 459 to 1       459/459
(100 %)
2 diff
(99.6 %id)
AA977397 2 pooled tumors (clear cell type), Kidney .a 1700 to 2150 475 to 25   AAA   451/451
(100 %)
16 diff
(96.5 %id)
W67656 heart .a 1703 to 2155 454 to 1   fully sequenced,   454/454
(100 %)
1 diff
(99.8 %id)
R98764 liver and spleen .a 1707 to 2108 403 to 1       403/403
(100 %)
2 diff
(99.6 %id)
H94089 placenta .a 1707 to 2153 1 to 457   fully sequenced,   457/457
(100 %)
15 diff
(96.8 %id)
AI141462 heart .a 1708 to 2154 447 to 1       447/456
(98 %)
1 diff
(99.8 %id)
AI128505 placenta .a 1709 to 2155 467 to 21   AAA   447/447
(100 %)
13 diff
(97.1 %id)
AI921960 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 1709 to 2157 451 to 3       449/451
(99 %)
1 diff
(99.8 %id)
AI151242 placenta .a 1710 to 2156 447 to 1       447/447
(100 %)
1 diff
(99.8 %id)
AI091781 heart .a 1712 to 2156 444 to 1       444/444
(100 %)
2 diff
(99.6 %id)
R83797 breast .a 1718 to 1904 1 to 187   fully sequenced,   187/187
(100 %)
1 diff
(99.5 %id)
R86077 breast .a 1719 to 2067 1 to 353       351/353
(99 %)
4 diff
(98.9 %id)
AI285060 adenocarcinoma, colon .a 1719 to 2150 450 to 21   AAA   430/434
(99 %)
28 diff
(93.6 %id)
BP393080 pancreatic islet .a 1723 to 2150 1 to 428     Submitted on the opposite strand 428/428
(100 %)
1 diff
(99.8 %id)
W69821 heart .a 1724 to 2151 435 to 1       435/436
(99 %)
8 diff
(98.2 %id)
AA171731   .a 1724 to 2152 429 to 1       429/429
(100 %)
1 diff
(99.8 %id)
N24591 melanocyte .a 1725 to 2157 440 to 3       436/440
(99 %)
11 diff
(97.5 %id)
BM856132 stomach .a 1734 to 2017 1 to 287       287/287
(100 %)
8 diff
(97.3 %id)
BF088493 head_neck .a 1736 to 2083 348 to 1       348/348
(100 %)
4 diff
(98.9 %id)
N78956.
matches multiple genes
lung .a 1751 to 2154 410 to 1     also hits gene DUT 410/411
(99 %)
9 diff
(97.9 %id)
W57701 heart .a 1751 to 2151 401 to 1   fully sequenced,   401/401
(100 %)
1 diff
(99.8 %id)
R07504 liver and spleen .a 1754 to 2154 411 to 4       408/411
(99 %)
8 diff
(98.1 %id)
W67747 heart .a 1754 to 1937 184 to 1       184/184
(100 %)
1 diff
(99.5 %id)
AA886339 2 pooled tumors (clear cell type), Kidney .a 1769 to 2154 396 to 11   AAA   386/386
(100 %)
0 diff
(100 %id)
AA617776 lung, lung tumor .a 1772 to 1856 85 to 1       85/85
(100 %)
1 diff
(98.9 %id)
AI924456 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 1773 to 2153 381 to 1       381/672
(56 %)
0 diff
(100 %id)
FN070766 breast carcinoma .a 1783 to 1879 97 to 1     Submitted on the opposite strand 97/98
(98 %)
0 diff
(100 %id)
BQ021943 placenta .a 1790 to 2154 378 to 14   AAA   365/365
(100 %)
0 diff
(100 %id)
AI537416 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1800 to 2150 372 to 24   AAA   349/351
(99 %)
5 diff
(98.6 %id)
N63969 multiple sclerosis lesions .a 1801 to 2150 353 to 1   fully sequenced,   353/353
(100 %)
6 diff
(98.4 %id)
AI218987 placenta .a 1802 to 2150 357 to 11   AAA   347/348
(99 %)
17 diff
(95.2 %id)
AW207767   .a 1804 to 2154 364 to 14   AAA   351/351
(100 %)
1 diff
(99.8 %id)
AA261893 germinal center B cell .a 1805 to 2150 346 to 1   fully sequenced,   346/346
(100 %)
0 diff
(100 %id)
FN132812 breast carcinoma .a 1823 to 1907 1 to 84       84/85
(98 %)
2 diff
(97.7 %id)
AA888253 metastatic prostate bone lesion .a 1836 to 2149 16 to 329   AAA   315/329
(95 %)
12 diff
(96.4 %id)
AI865957 adenocarcinoma, Pancreas .a 1837 to 2150 309 to 1       309/363
(85 %)
9 diff
(97.6 %id)
R24036 placenta .a 1838 to 2145 311 to 1       311/311
(100 %)
4 diff
(98.8 %id)
AA463732 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1838 to 2150 313 to 1       313/313
(100 %)
0 diff
(100 %id)
AA853337 Bone, Hip .a 1844 to 2135 299 to 8       292/299
(97 %)
0 diff
(100 %id)
AA490914 germinal center B cell .a 1846 to 2157 314 to 3   fully sequenced,   312/314
(99 %)
1 diff
(99.7 %id)
R83361 breast .a 1874 to 2132 260 to 1   fully sequenced,   260/260
(100 %)
0 diff
(100 %id)
AA029111 uterus .a 1880 to 2150 286 to 16   fully sequenced, AAA   271/271
(100 %)
0 diff
(100 %id)
BX415044 thymus .a 1915 to 2120 205 to 1   fully sequenced,   205/205
(100 %)
1 diff
(99.6 %id)
H94090 placenta .a 1915 to 2132 219 to 1   fully sequenced,   219/219
(100 %)
0 diff
(100 %id)
BU730449 eye, RPE and Choroid .a 1915 to 2150 254 to 19   fully sequenced, AAA   236/236
(100 %)
0 diff
(100 %id)
FN055917 breast carcinoma .a 1919 to 2027 1 to 109       109/109
(100 %)
1 diff
(99.1 %id)
CB163486 Liver .a 1926 to 2150 239 to 14   AAA Submitted on the opposite strand 226/226
(100 %)
1 diff
(99.6 %id)
BQ020954 lung, Metastatic Chondrosarcoma .a 1943 to 2150 224 to 17   AAA   208/213
(97 %)
6 diff
(97.2 %id)
BG319462 skin .a 1948 to 2096 149 to 1     Submitted on the opposite strand 149/149
(100 %)
0 diff
(100 %id)
FN053091 breast carcinoma .a 1970 to 2069 1 to 100       100/100
(100 %)
0 diff
(100 %id)
AA593563 colon, colon tumor .a 1982 to 2039 58 to 1       58/58
(100 %)
1 diff
(98.3 %id)
EC507134 Prostate .a 1995 to 2086 13 to 103       93/103
(90 %)
7 diff
(93.3 %id)
BU680959 lung .a 2012 to 2150 155 to 17   AAA   139/139
(100 %)
0 diff
(100 %id)
BG033772 breast, mammary adenocarcinoma, cell line .b 1 to 656 4 to 666   tiling clone,   666/1001
(66 %)
14 diff
(98.7 %id)
NM_033306.2   .b 33 to 1384 1 to 1352 exact RefSeq,   1352/1352
(100 %)
0 diff
(100 %id)
U28977   .b 33 to 1383 1 to 1353 N22* tiling clone,   1353/1353
(100 %)
3 diff
(99.8 %id)
U28978   .b 33 to 1383 1 to 1351 exact tiling clone,   1351/1351
(100 %)
1 diff
(100.0 %id)
DA958503 Spleen .c 1 to 432 2 to 433   tiling clone, capped   432/432
(100 %)
0 diff
(100 %id)
DB334112 Spleen .c 936 to 1451 518 to 3   tiling clone,   516/518
(99 %)
1 diff
(99.9 %id)
DB267077 uterus .d 1 to 581 2 to 585   tiling clone, capped   584/584
(100 %)
6 diff
(99.0 %id)
DA958070 Spleen .d 3 to 550 2 to 549   tiling clone, capped   548/548
(100 %)
0 diff
(100 %id)
W38599 lung .d 17 to 489 1 to 485       483/488
(98 %)
16 diff
(96.8 %id)
U28979   .d 48 to 1262 1 to 1215 exact tiling clone,   1215/1215
(100 %)
1 diff
(100.0 %id)
AA307583 colon .d 53 to 611 1 to 559       559/559
(100 %)
2 diff
(99.7 %id)
CV572561 cornea, eye .d 58 to 671 1 to 615       615/615
(100 %)
1 diff
(99.9 %id)
W58058 heart .d 74 to 686 1 to 615       615/617
(99 %)
5 diff
(99.2 %id)
N90207 lung .d 918 to 1373 459 to 1   tiling clone,   459/459
(100 %)
7 diff
(98.5 %id)
TI_57240010   .e 1 to 774 32 to 804   tiling clone,   773/804
(96 %)
6 diff
(99.3 %id)
BI916547 brain .e 12 to 774 1 to 763       763/763
(100 %)
0 diff
(100 %id)
AK304222 trachea .e 276 to 1253 1 to 978 exact tiling clone,   978/978
(100 %)
4 diff
(99.6 %id)
AL050391 uterus .e 809 to 5551 1 to 4747   tiling clone, available from DKFZ, AAA   4747/4747
(100 %)
20 diff
(99.6 %id)
AL047324 uterus .e 810 to 1407 1 to 598       598/598
(100 %)
1 diff
(99.9 %id)
BX479398   .e 1925 to 2178 1 to 253   tiling clone,   253/253
(100 %)
7 diff
(97.3 %id)
BE940041 uterus_tumor .e 1957 to 2409 1 to 453   tiling clone,   453/454
(99 %)
9 diff
(98.1 %id)
T47302 placenta .e 2340 to 2652 1 to 318   tiling clone, Submitted on the opposite strand 318/318
(100 %)
7 diff
(97.8 %id)
AA773367 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 2717 to 3025 1 to 311   tiling clone,   311/311
(100 %)
9 diff
(97.2 %id)
N31802 melanocyte .e 2722 to 3241 1 to 531   tiling clone,   531/531
(100 %)
16 diff
(97.0 %id)
T47301 placenta .e 3027 to 3316 303 to 2   tiling clone, Submitted on the opposite strand 302/319
(94 %)
0 diff
(100 %id)
BE067630 breast .e 3604 to 3849 245 to 1   tiling clone, Submitted on the opposite strand 245/245
(100 %)
5 diff
(98.0 %id)
BE067523 breast .e 3612 to 3741 9 to 137       129/137
(94 %)
6 diff
(95.7 %id)
AW384410 head_neck .e 3615 to 3865 249 to 1       249/253
(98 %)
7 diff
(97.3 %id)
AW384422 head_neck .e 3617 to 3858 246 to 6       241/246
(97 %)
0 diff
(100 %id)
BE693637 breast .e 3629 to 3877 1 to 249   tiling clone,   249/253
(98 %)
3 diff
(98.9 %id)
AW384421 head_neck .e 3635 to 3874 1 to 238       238/238
(100 %)
2 diff
(99.2 %id)
AW363593 colon .e 3673 to 3874 1 to 203       203/203
(100 %)
6 diff
(97.1 %id)
H21700 breast .e 3842 to 4225 13 to 403   tiling clone,   391/409
(95 %)
14 diff
(96.6 %id)
H45000 breast .e 3842 to 4145 1 to 306       306/363
(84 %)
6 diff
(98.4 %id)
DA572637 whole embryo, mainly body .e 4033 to 4534 338 to 834   capped   497/834
(59 %)
17 diff
(98.0 %id)
AW956501   .e 4043 to 4516 1 to 474   tiling clone,   474/475
(99 %)
3 diff
(99.4 %id)
AA342115 Spleen .e 4080 to 4432 1 to 358       358/358
(100 %)
11 diff
(97.0 %id)
AA308971 aorta .e 4145 to 4424 1 to 281       281/281
(100 %)
5 diff
(98.3 %id)
BE142051 head_neck .e 4316 to 4552 246 to 10     Submitted on the opposite strand 237/246
(96 %)
0 diff
(100 %id)
BG673958 skin .e 4428 to 5270 1 to 838   tiling clone,   838/840
(99 %)
16 diff
(98.1 %id)
R09466 liver and spleen .e 4439 to 4799 1 to 374   tiling clone,   374/400
(93 %)
19 diff
(95.3 %id)
N46119 multiple sclerosis lesions .e 4488 to 4708 1 to 221       221/222
(99 %)
3 diff
(98.7 %id)
BM991934 Bone, Subchondral Bone .e 4526 to 4866 359 to 19   AAA   341/341
(100 %)
11 diff
(96.8 %id)
TI_149305579   .e 4697 to 5555 981 to 128   AAA   854/976
(87 %)
27 diff
(97.3 %id)
BQ365346 placenta_normal .e 4827 to 5281 463 to 3       461/463
(99 %)
0 diff
(100 %id)
W39601 parathyroid gland, parathyroid tumor .e 4864 to 5146 1 to 291   fully sequenced,   291/291
(100 %)
5 diff
(98.3 %id)
BU753572 placenta .e 4872 to 5556 703 to 18   AAA   686/686
(100 %)
6 diff
(99.2 %id)
BU685911 lung, Primary Lung Epithelial Cells .e 4960 to 5558 605 to 7       599/605
(99 %)
0 diff
(100 %id)
BF056078 pooled .e 4970 to 5554 589 to 5       585/589
(99 %)
0 diff
(100 %id)
AL047325 uterus .e 4977 to 5551 600 to 26   AAA   575/575
(100 %)
1 diff
(99.9 %id)
AW007558 colon .e 4981 to 5551 583 to 13   AAA   571/571
(100 %)
2 diff
(99.7 %id)
AA772355 parathyroid gland, parathyroid tumor .e 4983 to 5554 576 to 5       572/576
(99 %)
0 diff
(100 %id)
DB359704 whole embryo, mainly body .e 5004 to 5558 554 to 2       553/558
(99 %)
0 diff
(100 %id)
BF435297 pooled .e 5021 to 5554 538 to 5       534/538
(99 %)
0 diff
(100 %id)
TI_149286404   .e 5068 to 5551 574 to 92   tiling clone, AAA   483/517
(93 %)
1 diff
(99.9 %id)
N46120 multiple sclerosis lesions .e 5074 to 5556 491 to 1       491/533
(92 %)
11 diff
(98.0 %id)
BQ013884 placenta .e 5074 to 5556 500 to 18   AAA   483/488
(98 %)
1 diff
(99.8 %id)
BM971990 lung .e 5076 to 5551 492 to 17   AAA   476/477
(99 %)
0 diff
(100 %id)
AI381499 pooled .e 5092 to 5558 468 to 2   tiling clone,   467/468
(99 %)
0 diff
(100 %id)
TI_149284475   .e 5098 to 5555 545 to 87   AAA   459/1171
(39 %)
4 diff
(99.7 %id)
CB854621 lung, Primary Lung Epithelial Cells .e 5098 to 5555 477 to 19   AAA   459/467
(98 %)
4 diff
(99.2 %id)
W15436 parathyroid gland, parathyroid tumor .e 5117 to 5558 446 to 2   fully sequenced,   445/446
(99 %)
0 diff
(100 %id)
H44953 breast .e 5145 to 5536 396 to 1       396/397
(99 %)
6 diff
(98.5 %id)
AI436274 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 5147 to 5551 405 to 1       405/405
(100 %)
7 diff
(98.3 %id)
BU753869 placenta .e 5164 to 5556 411 to 19   AAA   393/393
(100 %)
7 diff
(98.3 %id)
BM855314 stomach .e 5194 to 5509 1 to 316       316/316
(100 %)
1 diff
(99.7 %id)
AA954293 pooled .e 5195 to 5557 363 to 1       363/363
(100 %)
1 diff
(99.8 %id)
H21908 breast .e 5299 to 5543 249 to 5       245/249
(98 %)
0 diff
(100 %id)
AI572301 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 5319 to 5551 243 to 11   AAA   233/233
(100 %)
0 diff
(100 %id)
AA971903 pooled .e 5321 to 5555 237 to 3       235/237
(99 %)
0 diff
(100 %id)
AA767246 germinal center B cell .e 5372 to 5555 197 to 14   AAA   184/184
(100 %)
0 diff
(100 %id)
CB145253 Liver .f 1 to 414 4 to 417   tiling clone,   417/417
(100 %)
0 diff
(100 %id)
R06473 liver and spleen .f 20 to 277 1 to 262       262/262
(100 %)
7 diff
(97.4 %id)
CB122645 Liver .f 28 to 611 1 to 584   tiling clone,   584/584
(100 %)
0 diff
(100 %id)
AA149566 colon, tumor .f 40 to 509 1 to 466   fully sequenced,   466/466
(100 %)
4 diff
(99.2 %id)
AA151692 colon, tumor .f 479 to 1001 519 to 1   tiling clone, fully sequenced,   519/519
(100 %)
7 diff
(98.7 %id)
R06418 liver and spleen .f 684 to 999 321 to 4       318/450
(70 %)
5 diff
(98.9 %id)
DC409075 thymus .g 1 to 576 1 to 577 N36E W37L K38E E39G E40R ... tiling clone,   577/577
(100 %)
1 diff
(99.9 %id)
AK296081 thalamus .g 7 to 927 1 to 921 exact tiling clone,   921/921
(100 %)
1 diff
(99.9 %id)
DC339685 thalamus .g 7 to 551 1 to 546 L35X N36E W37L K38E E39G ...     546/546
(100 %)
1 diff
(99.9 %id)
AW770565 carcinoid, lung .g 97 to 740 647 to 4       644/648
(99 %)
17 diff
(97.4 %id)
AI350321 carcinoid, lung .g 299 to 740 445 to 4       442/445
(99 %)
0 diff
(100 %id)
AI914340 carcinoid, lung .g 300 to 740 444 to 4       441/444
(99 %)
0 diff
(100 %id)
BE731563 choriocarcinoma, placenta .h 1 to 771 1 to 789 T76M C77M F78L Q79P K80E ... tiling clone,   789/794
(99 %)
34 diff
(95.8 %id)
AI302683 carcinoid, lung .h 608 to 1200 1 to 593   tiling clone, Submitted on the opposite strand 593/593
(100 %)
1 diff
(99.9 %id)
BX116810 placenta .h 861 to 1527 1 to 667   tiling clone,   667/667
(100 %)
1 diff
(99.9 %id)
R25422 placenta .h 908 to 1132 1 to 235       235/240
(97 %)
13 diff
(94.6 %id)
R69217 placenta .h 908 to 1197 1 to 303   fully sequenced,   303/303
(100 %)
6 diff
(98.1 %id)
AI766124 Kidney .h 1038 to 1530 493 to 1       493/493
(100 %)
2 diff
(99.6 %id)
R26253 placenta .h 1165 to 1534 376 to 1       376/376
(100 %)
8 diff
(97.9 %id)
R69102 placenta .h 1167 to 1534 371 to 1   fully sequenced,   371/371
(100 %)
5 diff
(98.7 %id)
BF109678 pooled .h 1187 to 1537 353 to 2   tiling clone,   352/353
(99 %)
0 diff
(100 %id)
AI032896 liver and spleen .h 1200 to 1531 332 to 1   tiling clone,   332/332
(100 %)
0 diff
(100 %id)
BM987387 Bone, Subchondral Bone .i 1 to 682 709 to 19 exact tiling clone, AAA   691/691
(100 %)
6 diff
(99.2 %id)
DB139722 thymus .j 1 to 537 2 to 539 exact tiling clone, capped   538/538
(100 %)
1 diff
(99.9 %id)
DA677656   .j 99 to 666 2 to 570 D47X A48C K49* tiling clone, capped   569/569
(100 %)
2 diff
(99.7 %id)
DA546720   .k 1 to 455 2 to 453 A2Y tiling clone, capped   452/455
(99 %)
8 diff
(98.3 %id)
BX346218   .k 14 to 1024 1 to 1007 K43X K87X tiling clone, to resequence,   1007/1007
(100 %)
17 diff
(98.4 %id)
BX346217   .k 1097 to 1815 720 to 1   tiling clone, to resequence,   720/720
(100 %)
2 diff
(99.8 %id)
N92740 lung .l 1 to 215 215 to 1 exact tiling clone,   215/224
(95 %)
0 diff
(100 %id)
DA832966 placenta .m 1 to 744 2 to 748   tiling clone, capped   747/749
(99 %)
8 diff
(99.0 %id)
DB379441 placenta .m 1420 to 1893 471 to 2 S2G G3L C4* tiling clone,   470/477
(98 %)
9 diff
(98.2 %id)
DA677846   .n 1 to 591 3 to 594   tiling clone, capped   593/593
(100 %)
2 diff
(99.7 %id)
DB322470   .n 1265 to 1795 533 to 1   tiling clone,   533/533
(100 %)
3 diff
(99.5 %id)
BI836836 pooled pancreas and spleen .o-u 1 to 887 1 to 897 N18* tiling clone,   897/897
(100 %)
18 diff
(98.0 %id)
TI_57164185   .o-u 1 to 887 69 to 965 N18*     897/965
(92 %)
6 diff
(99.4 %id)
FN117632 breast carcinoma .o-u 560 to 663 1 to 99   tiling clone,   99/99
(100 %)
5 diff
(95.0 %id)
BE467978 carcinoid, lung .p-u 1 to 546 546 to 1 N19X tiling clone,   546/546
(100 %)
0 diff
(100 %id)
BE503626 carcinoid, lung .p-u 58 to 546 501 to 13   AAA   489/489
(100 %)
0 diff
(100 %id)
AW770598 carcinoid, lung .p-u 78 to 541 469 to 6       464/469
(98 %)
0 diff
(100 %id)
AW770768 carcinoid, lung .p-u 109 to 546 450 to 13   AAA   438/438
(100 %)
0 diff
(100 %id)
AV692502 hepatocellular carcinoma Gene CASP4, variant not shown         Suspected internal deletion, this clone was ignored    
BQ694188 adipose Gene CASP4, variant not shown              
AV657667 corresponding non cancerous liver tissue Gene CASP4, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
DB322267   Gene CASP4, variant not shown              
DA672031   Gene CASP4, variant not shown       capped      
CF597449 ovary Gene CASP4, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o-u, .p-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI